+34 679 490 537info@nanbiosis.com



U3-S02. Modification of the peptides (On-site&Remote) OUTSTANDING

Modification of the peptides during and post synthesis to meet user requirements:

  • Binding to fluorophores and other types of molecules.
  • Conjugation to KLH protein or other carriers for immunization.
3. Peptides-System for acidolactic cleavage of the peptide resin boundby anhydrous HF
Read More

U3-S01. Synthesis of peptides and characterisation (On-site&Remote) OUTSTANDING

Synthesis of peptides at various different scales (100 mg to grams) and Purification and characterisation using HPCL and HPLC -MS .

Read More

U2-S01. Scientific and technical support (Remote)

Scientific and technical support and advice on immunogen design, immunoreagent synthesis and production, antibody production and immunoassay design and development.

Read More

U6-S14. Quantitative studies of biomolecular interactions by calorimetric measurements (On-site) OUTSTANDING

Quantitative studies of biomolecular interactions by calorimetric measurements.

Read More

U1-S03: Proteins purification (On-site&Remote) OUTSTANDING

  • Identification of the most appropriate strategy for purification, given the physical and chemical properties, opting either for purification modules or, in the case of fusion proteins, elements which enable purification by affinity.
  • Purification (downstream processing) using FPLC chromatography and/or tangential filtration.
  • Quality control of the purified protein ( molecular weight and purity by SDS-PAGE, biological activity, conformation by FTIR and DLS.
Read More

U1-S02. Bioproduction of proteins (On-site&Remote) OUTSTANDING

  • Production of the plasmid DNA that contains the gene of the relevant protein to be incorporated into the producing cells by transformation/transfection.
  • Selection of the optimal protein production conditions using small and medium-scale expression; confirmation of the expression using Westernblot and SDS-PAGE analysis and quantification by densitometry.
  • Measurements of the solubility/aggregation of the protein under study.
  • Scale-up of the upstream processing in bioreactors or incubator shaker according to requirements.”
Read More

U1-S01. Molecular cloning (On-site&Remote) OUTSTANDING

  • Identification of the most appropriate system, selecting between Escherichia coli, insect cells (with expression systems based on infection with Baculovirus) and mammalian cells, according to the characteristics of the desired protein in terms of its size, modifications, etc.
  • Cloning of the gene that codifies for the protein of interest in the chosen expression vector; selection of the positive genes and their characterization by sequencing.
Read More